Involvement of the peripheral cholinergic muscarinic system in the compensatory ovarian hypertrophy in the rat

Experimental Biology and Medicine

Volumn 229, Issue 8, 2004, Pages 793-805

  Trkulja, Vladimir ^a   Crljen Manestar, Vladiana ^a   Banfic, Hrvoje ^a   Lackovic, Zdravko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Compensatory ovarian hypertrophy; Muscarinic receptors; Vagus

Indexed keywords

BETHANECHOL; BOTULINUM TOXIN; CARBACHOL; DIACYLGLYCEROL; DNA; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PHOSPHATIDYLINOSITIDE; PROPANTHELINE BROMIDE; PROTEIN; RNA; SCOPOLAMINE; THYMIDINE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; OVARY HYPERTROPHY; PROTEIN CONTENT; RAT; RECEPTOR BINDING; VAGOTOMY; VAGUS NERVE;

ANIMALIA; FALLOPIA;

EID: 4444259142     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422900812     Document Type: Article

References (63)

1. Batra S, Popper LD, Iosif CS. Characterization of muscarinic cholinergic receptors in human ovaries, ovarian tumours and tumour cell lines. Eur J Cancer 29A:1302-1306, 1993.
2. Fritz S, Fohr KJ, Boddien S, Berg U, Brucker C, Mayerhofer A. Functional and molecular characterization of a muscarinic receptor type and evidence for expression of choline-acetyltransferase and vesicular acetylcholine transporter in human granulosa-luteal cells. J Clin Endocrin Metab 84:1744-1750, 1999.
3. Fritz S, Wessler I, Breitling R, Rossmanith W, Ojeda SR, Dissen GA, Amsterdam A, Mayerhofer A. Expression of muscarinic receptor types in the primate ovary and evidence for nonneuronal acetylcholine synthesis. J Clin Endocrin Metab 86:349-354, 2001.
4. Mayerhofer A, Fohr KJ, Sterzik K, Gratzl M. Carbachol increases intracellular free calcium concentrations in human granulosa-lutein cells. J Endocrinol 135:663-670, 1992.
5. Fritz S, Kunz L, Dimitrijevic N, Grunert R, Heiss C, Mayerhofer A. Muscarinic receptors in human luteinized granulosa cells: activation blocks gap junctions and induces the transcription factor egr-1. J Clin Endocrin Metab 87:1362-1367, 2002.
6. + channel in the ovary: identification, characterization and functional involvement in steroidogenesis. J Clin Endocrin Metab 87:5566-5574, 2002.
7. Popper LD, Batra S. Muscarinic acetylcholine and histamine receptor mediated calcium mobilization and cell growth in human ovarian cancer cells. Int J Oncol 4:453-459, 1994.
8. Luck MR. Cholinergic stimulation, through muscarinic receptors, of oxytocin and progesterone secretion from bovine granulosa cells undergoing spontaneous luteinization in serum-free culture. Endocrinology 126:1256-1263, 1990.
9. Kornya L, Bodis J, Koppan M, Tinneberg HR, Torok A. Modulatory effect on acetylcholine on gonadotropin-stimulated human granulosa cell steroid secretion. Gyn Obst Invest 52:104-107, 2001.
10. Bodis J, Tinneberg HR, Papenfuss F, Torok A, Cledon P, Hanf V, Schwarz H. Cholinergic stimulation of progesterone and estradiol secretion by human granulosa cells cultured in serum-free medium. Gynecol Endocrinol 7:83-87, 1993.
11. Fritz S, Grunert R, Stocco DM, Hales DB, Mayerhofer A. StAR protein is increased by muscarinic receptor activation in human luteinized granulosa cells. Mol Cell Endocrinol 171:49-51, 2001.
12. Casper RF, Cotterell MA. The effects of adrenergic and cholinergic agents on progesterone production by human corpus luteum in vitro. Am J Obst Gyn 148:663-669, 1984.
13. Kasson BG, Hsueh AJ. Cholinergic inhibition of follicle-stimulating hormone-induced progestin production by cultured rat granulosa cells. Biol Reprod 33:1158-1167, 1985.
14. Morley P, Tsang BK, Whitfield JF, Schwartz JL. The effect of muscarinic cholinergic agonists on intracellular calcium and progesterone production by chicken granulosa cells. Endocrinology 130:663-670, 1992.
15. Cooke RG, Payne JH. Effects of arterial infusion of adrenalin and acetylcholine on luteal secretion of progesterone and oxytocin in goats. Theriogenology 50:153-159, 1998.
16. Aguado LI. Role of the central and peripheral nervous system in the ovarian function. Microsc Res Tech 59:462-473, 2002.
17. D'Albora H, Anesetti G, Lombide P, Dees WL, Ojeda SR. Intrinsic neurons in the mammalian ovary. Microsc Res Tech 59:484-489, 2002.
18. Jacobowitz D, Wallach EE. Histochemical and chemical studies of the autonomic innervation of the ovary. Endocrinology 81:1132-1139, 1967.
19. Burden HW, Lawrence IE Jr. Experimental studies on the acetylcholinesterase-positive nerves in the ovary of the rat. Anat Rec 190:233-241, 1978.
20. Myerhofer A, Fritz S. Ovarian acetylcholine and muscarinic receptors: hints of a novel intrinsic ovarian regulatory system. Microsc Res Tech 59:503-508, 2002.
21. Mayerhofer A, Dimitrijevic N, Kunz L. The expression and biological role of the non-neural cholinergic system in the ovary. Life Sci 72:2039-2045, 2003.
22. Trkulja V, Lackovic Z. Involvement of muscarinic receptors in the control of female puberty in the rat. Eur J Pharmacol 297:93-96, 1996.
23. Trkulja V, Lackovic Z. Autonomic neural control of the ovary: does the peripheral muscarinic system participate? Period Biol 99:499-503, 1997.
24. Greenwald GS. Quantitative study of follicular development in the ovary of the intact and unilaterally ovariectomized hamster. J Reprod Fertil 2:351-361, 1961.
25. Trkulja V, Lackovic Z. Vagal influence on compensatory ovarian growth is important only briefly after hemicastration. Exp Biol Med 226:776-781, 2001.
26. Munro HW, Fleck A. Recent developments in the measurement of nucleic acids in biological materials. Analyst 91:78-84, 1966.
27. Lowry OH, Tosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 193:265-278, 1951.
28. Burton KA. A study of the conditions and mechanisms of diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-322, 1956.
29. 3H] thymidine into hamster follicles during the oestrous cycle. J Reprod Fertil 77:143-152, 1986.
30. Chiras DD, Greenwald GS. Analysis of ovarian follicular development and thymidine incorporation in the cyclic golden hamster. Am J Anat 157:309-317, 1980.
31. Folch J, Lees MM, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957.
32. Crljen V, Volinia S, Banfic H. Hepatocyte growth factor activates phosphoinositide 3-kinase C2β in renal brush-border plasma membranes. Biochem J 365:791-799, 2002.
33. Divecha N, Banfic H, Irvine RF. The polyphospho-inositide cycle exits in the nuclei of Swiss 3T3 cells under control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J 10:3207-3214, 1991.
34. Divecha N, Irvine RF. Mass measurement of phosphatidyl inositol 4-phosphate and sn-1,2-diacylglycerols. In: Irvine RF, Ed. Methods in Inositide Research. New York: Raven, pp 179-185, 1990.
35. Welschen R. Effect of unilateral ovariectomy on follicular growth in hypophysectomized rats treated with pregnant mare serum gonadotrophin. J Endocrinol 55:227-228, 1972.
36. Cook B. Endocrine asymmetry. J Endocrinol 113:331-332, 1987.
37. Burden HW, Lawrence IE Jr. The effect of denervation on compensatory ovarian hypertrophy. Neuroendocrinology 23:368-378, 1977.
38. Fiorindo RP, Martini L. Evidence for a cholinergic component in the neuroendocrine control of the luteinizing hormone (LH) secretion. Neuroendocrinology 18:322-332, 1975.
39. Libertun C, McCann SM. Blockade of the postorchidectomy increase in gonadotropins by implants of atropine into the hypothalamus. Proc Soc Exp Biol Med 152:143-146, 1976.
40. Krsmanovic LZ, Mores N, Navarro CE, Saeed SA, Arora KK, Catt KJ. Muscarinic regulation of intracellular signaling and neurosecretion in gonadotropin-releasing hormone neurons. Endocrinology 139:4037-4043, 1998.
41. Koren D, Egozi Y, Sokolovsky M. Muscarinic involvement in the regulation of gonadotropin-releasing hormone in the cyclic rat. Mol Cell Endocrinol 90:87-93, 1992.
42. Libertun C, McCann SM. Blockade of the release of gonadotropins and prolactin by subcutaneous or intraventricular injection of atropine in male and female rats. Endocrinology 92:1714-1724, 1973.
43. Vijayan E, McCann SM. Effect of blockade of dopaminergic receptors on acetylcholine (Ach)-induced alterations of plasma gonadotropin and prolactin (Prl) in conscious ovariectomized rats. Brain Res Bull 5:23-29, 1980.
44. Piva F, Borrell J, Limonta P, Gavazzi G, Martini L. Cholinergic inputs to the amygdala and the control of gonadotrophin release. Acta Endocrinol 93:1-6, 1980.
45. Cruz ME, Villegas G, Dominguez-Gonzalez A, Chavira R, Dominguez R. Ovulation delay induced by blockade of the cholinergic system on dioestrus-1 is related to changes in dopaminergic activity of the preoptic anterior- hypothalamic area of the rat. Brain Res Bull 54:339-344, 2001.
46. Muller EE, Cella SG, DeGennaro Colona V, Parenti M, Cocchi D, Locatelli V. Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals. J Reprod Pertil Suppl 46:99-114, 1993.
47. Chu YC, Tsou MY, Pan JT. Prostaglandins may participate in opioidergic and cholinergic control of the diumal changes of tuberoinfundibular dopaminergic neuronal activity and serum prolactin level in ovariectomized estrogen-treated rats. Brain Res Bull 56:61-65, 2001.
48. Hull KL, Harvey S. GH as a co-gonadotropin: the relevance of the correlative changes in GH secretion and reproductive state. J Endocrinol 172:1-19, 2002.
49. Frasor J, Gibori G. Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 14:118-123, 2003.
50. Finkbeiner AE, Bissada NK, Welch LT. Uropharmacology: part VI. Parasympathetic depressants. Urology 10:503-510, 1977.
51. Finkbeiner AE, Bissada NK, Welch LT. Uropharmacology: part V. Choline esters and other parasympathomimetic drugs. Urology 10:83-89, 1977.
52. Dolly O. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. Headache 43(Suppl 1):S16-S24, 2003.
53. Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 43(Suppl 1):S9-S15, 2003.
54. Nance DM, King TR, Nance PW. Neuroendocrine and behavioral effects of intrathecal capsaicin in adult female rat. Brain Res Bull 18:109-114, 1987.
55. Moran C, Morales L, Razo RS, Apolonio J, Quiroz U, Chavira R, Dominguez R. Effects of sensorial denervation induced by capsaicin injection at birth or on day three of life, on puberty, induced ovulation and pregnancy. Life Sci 73:2113-2125, 2003.
56. Burden HW, Price GT, Davenport AT, Hodson CA. Dorsal rhizotomy does not alter rat estrous cycles or ovarian compensatory responses. Anat Embryol 187:461-464, 1993.
57. Leung PC, Steele GL. Intracellular signaling in the gonads. Endocr Rev 13:476-498, 1992.
58. Banfic H, Vuica M, Knotek M, Moslavac S, Divecha N. Inositol lipid signaling occurs in brush-border membranes during initiation of compensatory renal growth. Biochem J 295(Pt 2):599-605, 1993.
59. Sindic A, Aleksandrova A, Fields AP, Volinia S, Banfic H. Presence and activation of nuclear phosphoinositide 3-kinase C2beta during compensatory liver growth. J Biol Chem 276:17754-17761, 2001.
60. Divecha N, Irvine RF. Phospholipid signaling. Cell 80:269-278, 1995.
61. Costa LG, Guizzeti M, Oberdoerster J, Yagle K, Costa-Mallen P, Tita B, Bordi F, Vitalone A, Palmery M, Valeri P. Modulation of DNA synthesis by muscarinic cholinergic receptors. Growth Factor 18:227-236, 2001.
62. Gerendai I, Kocsis K, Halasz B. Supraspinal connections of the ovary: structural and functional aspects. Microsc Res Tech 59:474-483, 2002.
63. Gerendai I, Toth IE, Boldogkoi Z, Medveczky I, Halasz B. CNS structures presumably involved in vagal control of ovarian function. J Auton Nerv Syst 80:40-45, 2000.